Suppr超能文献

一名主要表现为胆囊炎的老年显微镜下多血管炎患者经咪唑立宾成功治疗的病例。

A case of microscopic polyangiitis in an elderly patient presenting predominantly with cholecystitis successfully treated with mizoribine.

作者信息

Ichinose Kunihiro, Iwanaga Nozomi, Okada Akitomo, Tamai Mami, Yamasaki Satoshi, Nakamura Hideki, Origuchi Tomoki, Kawakami Atsushi

机构信息

Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki , Japan.

出版信息

Mod Rheumatol. 2014 Nov;24(6):1011-4. doi: 10.3109/14397595.2013.874742. Epub 2014 Feb 11.

Abstract

An 82-year-old woman was previously diagnosed with cholecystitis and treated with antibiotics at another hospital. Because her fever and inflammation persisted, therapeutic cholecystectomy was performed. Histopathology of the gallbladder revealed periarterial vasculitis. After transfer to our hospital, an elevated titer of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) was observed (47 U/mL). The patient's renal dysfunction had previously been thought to be sequelae of her cholecystectomy. We diagnosed microscopic polyangiitis (MPA) and began treatment with 40 mg orally of prednisolone daily. The titer of MPO-ANCA decreased with the treatment, but fever recurred with prednisolone taper. We, therefore, added 50 mg orally of mizoribine (MZR) daily as an immunosuppressant and increased the MZR to 100 mg daily while monitoring its blood peak concentration. The peak level of MZR was 1.58 μg/mL at 6 h after administration. After adding MZR, we successfully tapered the orally dosed prednisolone without recurrent fever or complications. We describe this case of MPA in an elderly patient manifesting predominantly with cholecystitis and successfully treated with orally dosed prednisolone and MZR.

摘要

一名82岁女性此前在另一家医院被诊断为胆囊炎,并接受了抗生素治疗。由于她的发热和炎症持续存在,遂进行了治疗性胆囊切除术。胆囊组织病理学检查显示动脉周围血管炎。转至我院后,观察到髓过氧化物酶抗中性粒细胞胞浆抗体(MPO-ANCA)滴度升高(47 U/mL)。该患者的肾功能不全此前被认为是胆囊切除术后的后遗症。我们诊断为显微镜下多血管炎(MPA),并开始每日口服40 mg泼尼松龙进行治疗。随着治疗,MPO-ANCA滴度下降,但在泼尼松龙减量时发热复发。因此,我们每日加用50 mg口服咪唑立宾(MZR)作为免疫抑制剂,并在监测其血药峰浓度的同时将MZR增至每日100 mg。给药后6小时MZR的峰浓度为1.58 μg/mL。加用MZR后,我们成功地逐渐减少了口服泼尼松龙的剂量,未再出现发热或并发症。我们描述了这例以胆囊炎为主的老年MPA患者,并通过口服泼尼松龙和MZR成功治疗的病例。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验